Cited by 40Advanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsAdvancements in Transdermal Drug Delivery

Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization

Rostami, E., Kashanian, S., Azandaryani, A. H.·2014·Molecular Biology Reports

Abstract

The aim of this work was to produce and characterize solid lipid nanoparticles (SLN) containing levothyroxine sodium for oral administration, and to evaluate the kinetic release of these colloidal carriers. SLNs were prepared by microemulsion method. The particle size and zeta potential of levothyroxine sodium-loaded SLNs were determined to be around 153 nm,-43 mV (negatively charged), respectively by photon correlation spectroscopy. The levothyroxine entrapment efficiency was over 98%. Shape and surface morphology were determined by TEM and SEM. They revealed fairly spherical shape of nanoparticles.SLN formulation was stable over a period of 6 months. There were no significant changes in particle size, zeta potential and polydispersity index and entrapment efficiency, indicating that the developed SLNs were fairly stable.

Integrity signals

Registry

Crossref · 10.1007/s11033-014-3216-4

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rostami, E., Kashanian, S., & Azandaryani, A. H.
Affiliations
  • Islamic Azad University of Kermanshah (IR)
  • Razi University (IR)
Corresponding author
Kashanian, S.
Venue
Molecular Biology Reports
Published
2014-02-11
Volume
41
Issue
5
Pages
3521-3527
ISSN
  • 0301-4851 (ISSN-L)
  • 1573-4978
OpenAlex
W1963490643
Cited by
40
References
35
Citations by year
2026: 4 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 3
FWCI
1.13
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Biology Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
solid lipid nanoparticles, levothyroxine sodium, oral drug delivery, drug carriers, microemulsion method, drug release kinetics, encapsulation efficiency, particle size, zeta potential, nanoparticle stability, antithyroid drugs
MeSH terms
Drug Carriers, Kinetics, Lipids, Particle Size, Thyroxine, Drug Delivery Systems, Nanoparticles, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review